Syndax Pharmaceuticals
SNDX
SNDX
175 hedge funds and large institutions have $1.03B invested in Syndax Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 76 increasing their positions, 59 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
2% less call options, than puts
Call options by funds: $66.1M | Put options by funds: $67.5M
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
30% less capital invested
Capital invested by funds: $1.48B → $1.03B (-$447M)
Holders
175
Holding in Top 10
6
Calls
$66.1M
Puts
$67.5M
Top Buyers
| 1 | +$12.9M | |
| 2 | +$12.5M | |
| 3 | +$11.1M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$9.21M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$8.77M |
Top Sellers
| 1 | -$45.1M | |
| 2 | -$18.1M | |
| 3 | -$9.3M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$8.4M |
| 5 |
State Street
Boston,
Massachusetts
|
-$8.04M |